Drug Groups In India Expect Supply Shortage Later This Year
This article was originally published in PharmAsia News
The head of a pharmacy group in India expects a shortage of many drugs in India as of October, reaching as high as 80 percent by December. The general secretary of the All-India Organisation of Chemists and Druggists blames the coming shortage on the reduced bulk-drug supply from China and national price controls. He said his group expected the monthly business of pharmacies to drop by 75 percent during that period. Daara Patel, secretary in chief of the Indian Drug Manufacturers Association, said the pharmacies could see the absence of antibiotics and other drugs in the next few months due to the shortage of active pharmaceutical ingredients. (Click here for more
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
ClinROs, artificial intelligence-based algorithms will be included in approval pathway. FDA is taking a crash course on new techniques for trial assessment thanks to COVID.